First amyloid β1‐42 certified reference material for re‐calibrating commercial immunoassays
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
First amyloid β1‐42 certified reference material for re‐calibrating commercial immunoassays
Authors
Keywords
-
Journal
Alzheimers & Dementia
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-08-05
DOI
10.1002/alz.12145
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Towards a unified protocol for handling of CSF before β-amyloid measurements
- (2019) Shorena Janelidze et al. Alzheimers Research & Therapy
- CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts
- (2018) Oskar Hansson et al. Alzheimers & Dementia
- Commutability of the certified reference materials for the standardization of β-amyloid 1-42 assay in human cerebrospinal fluid: lessons for tau and β-amyloid 1-40 measurements
- (2018) Ulf Andreasson et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Effects of APOE ε4 on neuroimaging, cerebrospinal fluid biomarkers and cognition in prodromal Alzheimer’s disease
- (2018) Niklas Mattsson et al. NEUROBIOLOGY OF AGING
- Preanalytical Sample Handling and Sample Stability Testing for the Neurochemical Dementia Diagnostics
- (2018) Rüdiger Zimmermann et al. JOURNAL OF ALZHEIMERS DISEASE
- Qualification of a Surrogate Matrix-Based Absolute Quantification Method for Amyloid-β42 in Human Cerebrospinal Fluid Using 2D UPLC-Tandem Mass Spectrometry
- (2018) Magdalena Korecka et al. JOURNAL OF ALZHEIMERS DISEASE
- Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrations
- (2017) Ronald Lautner et al. Alzheimers Research & Therapy
- Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of β-amyloid (1–42) in human cerebrospinal fluid
- (2016) Tobias Bittner et al. Alzheimers & Dementia
- Round robin test on quantification of amyloid-β 1–42 in cerebrospinal fluid by mass spectrometry
- (2016) Josef Pannee et al. Alzheimers & Dementia
- Assessing the commutability of reference material formats for the harmonization of amyloid-β measurements
- (2016) Maria Bjerke et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Optimized Standard Operating Procedures for the Analysis of Cerebrospinal Fluid Aβ42 and the Ratios of Aβ Isoforms Using Low Protein Binding Tubes
- (2016) Hugo Marcel Johan Vanderstichele et al. JOURNAL OF ALZHEIMERS DISEASE
- Commutability of candidate reference materials for the harmonization of Aβ1-42 measurements, on behalf of the ifcc working group on CSF proteins
- (2015) Ulf Andreasson et al. Alzheimers & Dementia
- Importance and Impact of Preanalytical Variables on Alzheimer Disease Biomarker Concentrations in Cerebrospinal Fluid
- (2015) N. Le Bastard et al. CLINICAL CHEMISTRY
- Performance criteria for reference measurement procedures and reference materials
- (2015) Heinz Schimmel et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Amyloid biomarkers in Alzheimer's disease
- (2015) Kaj Blennow et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age
- (2015) Courtney L. Sutphen et al. JAMA Neurology
- Mass Spectrometry-Based Candidate Reference Measurement Procedure for Quantification of Amyloid- in Cerebrospinal Fluid
- (2014) A. Leinenbach et al. CLINICAL CHEMISTRY
- Amyloid-beta 42 adsorption following serial tube transfer
- (2014) Jamie Toombs et al. Alzheimers Research & Therapy
- Apolipoprotein E Genotype and the Diagnostic Accuracy of Cerebrospinal Fluid Biomarkers for Alzheimer Disease
- (2014) Ronald Lautner et al. JAMA Psychiatry
- CSF biomarker variability in the Alzheimer's Association quality control program
- (2013) Niklas Mattsson et al. Alzheimers & Dementia
- Alzheimer Disease Biomarker Testing in Cerebrospinal Fluid: A Method to Harmonize Assay Platforms in the Absence of an Absolute Reference Standard
- (2013) H. M. Vanderstichele et al. CLINICAL CHEMISTRY
- Reference measurement procedures for Alzheimer’s disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42
- (2012) Niklas Mattsson et al. Biomarkers in Medicine
- A standardized and biocompatible preparation of aggregate-free amyloid beta peptide for biophysical and biological studies of Alzheimer's disease
- (2011) K. Broersen et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Quantification of protein calibrants by amino acid analysis using isotope dilution mass spectrometry
- (2010) A. Muñoz et al. ANALYTICAL BIOCHEMISTRY
- Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
- (2010) Kaj Blennow et al. Nature Reviews Neurology
- Standardization of protein biomarker measurements: Is it feasible?
- (2010) Heinz Schimmel et al. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
- Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
- (2009) Leslie M. Shaw et al. ANNALS OF NEUROLOGY
- A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease
- (2009) N A Verwey et al. ANNALS OF CLINICAL BIOCHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search